June 10, 2008 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced that the company has been awarded another metabolomics patent. The newly issued patent further expands the domain of previously issued patents to include multiple disease states related to nervous systems disorders including Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, depression and schizophrenia... Metabolon's Press Release -
Friday, June 27, 2008
Metabolon : additional metabolomics patent
June 10, 2008 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced that the company has been awarded another metabolomics patent. The newly issued patent further expands the domain of previously issued patents to include multiple disease states related to nervous systems disorders including Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, depression and schizophrenia... Metabolon's Press Release -
